Pharmaceutical composition having improved pharmacokinetic properties

HK40137404APending Publication Date: 2026-09-11SICHUAN PURITY PHARM CO LTD
View PDF 0 Cites -1 Cited by

Patent Information

Application Number
HK62026125106
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-09-21
Filing Date
2026-06-22
Publication Date
2026-09-11
Patent Text Reader

Abstract

The invention provides a novel pharmaceutical composition. The novel pharmaceutical composition is mainly composed of alkyl glycoside and an active component shown in a formula I, the invention accidentally finds that the combined use of the alkyl glycoside can obviously and unexpectedly improve multiple PK characteristics of the active component shown in the formula I, such as Cmax improvement by more than 10 times, even 52.2 times, AUC0-inf improvement by more than 5.1 times, even 17.1 times, and Tmax improvement which is shortened to 0.17 h or less more quickly. Based on the excellent improved PK characteristics, the bioavailability can be remarkably enhanced, the blood concentration can be quickly improved, the dosage of administration is expected to be further reduced, the medication safety is improved, and the compound is particularly suitable for treating, relieving and preventing acute attack of migraine and neuropathic pain indications.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480059263.1 (22) Application Date 2024.09.20 (66) Domestic Priority Data 202311223970.3 2023.09.21 CN (85) PCT International Application Entering National Phase Date 2026.03.16 (86) PCT International Application Application Data PCT / CN2024 / 120008 2024.09.20 (87) PCT International Application Publication Data WO2025 / 061141 ZH 2025.03.27 (71) Applicant Sichuan Prite Pharmaceutical Co., Ltd. Address 610096 No. 566, Antai Fifth Road, High-tech Zone, Chengdu, Sichuan Province (72) Inventors: Liu Chengran, Wang Zhenyu, Wang Hairong, Yang Hao, Chen Yashu, Du Shuwen, Yang Anle, Zou Lianxin, Li Zerui (74) Patent Agency: Beijing Xinno Chuangcheng Intellectual Property Agency Co., Ltd. 11728 Patent Attorneys: Wang Yu, Chen Yuejun (51) Int.Cl. A61K 31 / 435 (2006.01) A61K 9 / 48 (2006.01) A61K 31 / 404 (2006.01) A61K 9 / 20 (2006.01) A61K 31 / 196 (2006.01) C07K 14 / 705 (2006.01) (54) Invention Title: Pharmaceutical Composition with Improved Pharmacokinetic Properties (57) Abstract: This disclosure provides a novel pharmaceutical composition, mainly composed of an alkyl glycoside and an active ingredient represented by Formula I. This invention unexpectedly discovered that the combined use of alkyl glycosides can significantly and unexpectedly improve multiple PK properties of the active ingredient shown in Formula I, such as a Cmax improvement of more than 10 times, even up to 52.2 times, an AUC0-inf improvement of more than 5.1 times, even up to 17.1 times, and a Tmax improvement that is shortened more rapidly to 0.17 h or less. Based on these excellent improved PK properties, bioavailability can be significantly enhanced and blood drug concentration can be rapidly increased, which is expected to further reduce the dosage and improve drug safety, especially for the treatment, relief and prevention of acute attacks of migraine and neuropathic pain. CN 121909031 A 2026.04.21 CN 1 21 90 90 31 A